143

Neurology
Focuses on brain health.
Sub Categories on Neurology
Latest Articles
Knowing you have a brain aneurysm may raise risk of anxiety, other mental health conditions

Knowing you have a brain aneurysm may raise risk of anxiety, other mental health conditions

byAmerican Heart AssociationCredit: CC0 Public DomainAmong people who had aneurysms (weakened areas in brain blood vessels), the risk of developing a mental health condition was higher than amon

Knowing you have a brain aneurysm may raise risk of anxiety, other mental health conditions

byAmerican Heart AssociationCredit: CC0 Public DomainAmong people who had aneurysms (weakened areas in brain blood vessels), the risk of developing a mental health condition was higher than amon
Plotting the demise of Alzheimer's: New study is major test for power of early action

Plotting the demise of Alzheimer's: New study is major test for power of early action

by Alvin Powell,Harvard UniversityCredit: Harvard UniversityCatch it early. Those are watchwords in the battle against a host of illnesses, from heart disease to cancer to Type 2 diabetes. Early

Plotting the demise of Alzheimer's: New study is major test for power of early action

by Alvin Powell,Harvard UniversityCredit: Harvard UniversityCatch it early. Those are watchwords in the battle against a host of illnesses, from heart disease to cancer to Type 2 diabetes. Early
Twice daily electrical stimulation may boost mental processes in Alzheimer's disease, clinical trial suggests

Twice daily electrical stimulation may boost mental processes in Alzheimer's disease, clinical trial suggests

by British Medical JournalCredit: Wikimedia CommonsTwice daily non-invasive electrical stimulation of the brain may boost mental processes (cognitive function) in people with Alzheimer's dise

Twice daily electrical stimulation may boost mental processes in Alzheimer's disease, clinical trial suggests

by British Medical JournalCredit: Wikimedia CommonsTwice daily non-invasive electrical stimulation of the brain may boost mental processes (cognitive function) in people with Alzheimer's dise
Discovery of early plasma biomarkers for Alzheimer's disease

Discovery of early plasma biomarkers for Alzheimer's disease

by Institut national de la recherche scientifiqueINRS Professor Charles Ramassamy, specialist on Alzheimer's disease, doctoral student Mohamed Raâfet Ben Khedher and postdoctoral student Mohamed H

Discovery of early plasma biomarkers for Alzheimer's disease

by Institut national de la recherche scientifiqueINRS Professor Charles Ramassamy, specialist on Alzheimer's disease, doctoral student Mohamed Raâfet Ben Khedher and postdoctoral student Mohamed H
'Resetting' the injured brain offers clues for concussion treatment

'Resetting' the injured brain offers clues for concussion treatment

by Emily Caldwell,The Ohio State UniversityCredit: Unsplash/CC0 Public DomainNew research in mice raises the prospects for development of post-concussion therapies that could ward off cognitive

'Resetting' the injured brain offers clues for concussion treatment

by Emily Caldwell,The Ohio State UniversityCredit: Unsplash/CC0 Public DomainNew research in mice raises the prospects for development of post-concussion therapies that could ward off cognitive
Older class of type 2 diabetes drugs, glitazones, linked to 22% reduction in dementia risk

Older class of type 2 diabetes drugs, glitazones, linked to 22% reduction in dementia risk

by British Medical JournalCredit: Pixabay/CC0 Public DomainUse of an older class of type 2 diabetes drugs called glitazones, also known as thiazolidinediones or TZDs for short, is linked to a 22%

Older class of type 2 diabetes drugs, glitazones, linked to 22% reduction in dementia risk

by British Medical JournalCredit: Pixabay/CC0 Public DomainUse of an older class of type 2 diabetes drugs called glitazones, also known as thiazolidinediones or TZDs for short, is linked to a 22%
Brain neurons re-entering the cell cycle age quickly and shift to senescence, particularly in neurodegenerative disease

Brain neurons re-entering the cell cycle age quickly and shift to senescence, particularly in neurodegenerative disease

byPublic Library of ScienceSummary image of the article. The upper part highlights neuronal cell cycle re-engagement is a stage proceeding neuronal senescence and that their full molecular profi

Brain neurons re-entering the cell cycle age quickly and shift to senescence, particularly in neurodegenerative disease

byPublic Library of ScienceSummary image of the article. The upper part highlights neuronal cell cycle re-engagement is a stage proceeding neuronal senescence and that their full molecular profi
Medication may stop migraines before headache starts, study shows

Medication may stop migraines before headache starts, study shows

byAmerican Academy of NeurologyCredit: Unsplash/CC0 Public DomainWhen taken at the first signs of a migraine, before headache pain begins, a drug called ubrogepant may be effective in helping pe

Medication may stop migraines before headache starts, study shows

byAmerican Academy of NeurologyCredit: Unsplash/CC0 Public DomainWhen taken at the first signs of a migraine, before headache pain begins, a drug called ubrogepant may be effective in helping pe
Could marriage stave off dementia?

Could marriage stave off dementia?

by Michigan State UniversityHui Liu, professor of sociology. Credit: G.L. KohuthDementia and marital status could be linked, according to a new Michigan State University study that found married

Could marriage stave off dementia?

by Michigan State UniversityHui Liu, professor of sociology. Credit: G.L. KohuthDementia and marital status could be linked, according to a new Michigan State University study that found married
Trial begins of nasal vaccine for Alzheimer's disease

Trial begins of nasal vaccine for Alzheimer's disease

(HealthDay)—The first human clinical trial of a nasal vaccine to slow the progression of Alzheimer's disease is set to begin after nearly 20 years of research.This is a "remarkable milestone,

Trial begins of nasal vaccine for Alzheimer's disease

(HealthDay)—The first human clinical trial of a nasal vaccine to slow the progression of Alzheimer's disease is set to begin after nearly 20 years of research.This is a "remarkable milestone,